Mesothelioma Trial, Recruiting NCT07330271 Sponsor: Beijing Tsinghua Chang Gung Hospital Condition: Mesothelioma
Back to Mesothelioma

Mesothelioma Trial, Recruiting

NCT07330271
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with a specific type of cancer called epithelioid or biphasic malignant peritoneal mesothelioma, confirmed by a tissue test
  • You are already planned to have a major surgery to remove tumours from the abdomen, along with a heated chemotherapy wash during surgery, followed by further treatment afterwards
  • Enough tumour tissue can be collected during your surgery to be used for special drug sensitivity testing in the lab
  • You are well enough to carry out most daily activities, as measured by a standard health scoring tool (confirm with trial site)
  • Your blood cell counts are at an acceptable level, meaning your white blood cells and platelets are not too low
  • Your liver is functioning well enough, based on standard blood tests
  • Your kidneys are functioning well enough, based on a standard blood test
  • Your heart and lungs are healthy enough to safely undergo major surgery, as judged by the medical team
  • You are willing to take part voluntarily, sign a consent form, and follow the study requirements

Who may not be able to join:

  • You have another serious medical condition that, in the doctor's opinion, would make it unsafe for you to receive the study treatment
  • You have been recently diagnosed with another active cancer that could affect the study results
  • The medical team feels you are not suitable to take part for personal, psychological, family, or social reasons (confirm with trial site)
  • You are not willing to accept the treatment plan or attend the required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615030413619

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tsinghua Chang Gung Hospital
Registry
ClinicalTrials.gov
Start date
2 December 2025
Est. completion
1 November 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov